Study on the bioequivalence of two ranitidine formulations. 1987

C Hilgenstock, and G Schmiedel, and K G Bührens
Instrumentelle Analytik, McKnight Laboratories GmbH, Hamburg, Fed. Rep. of Germany.

Two 150 mg ranitidine containing tablet formulations were administered to 10 healthy volunteers in order to examine the biological equivalence. The study considered the area under the curve as the most important parameter, and also the duration of suppression of the gastric acid to 50%, based on a threshold concentration of ranitidine in serum of 165 ng/ml. The evaluation of data by statistical means shows that the formulations are equivalent.

UI MeSH Term Description Entries
D008297 Male Males
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013810 Therapeutic Equivalency The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Bioequivalence,Clinical Equivalency,Equivalency, Therapeutic,Generic Equivalency,Clinical Equivalencies,Equivalencies, Clinical,Equivalencies, Therapeutic,Equivalency, Clinical,Therapeutic Equivalencies,Bioequivalences,Equivalencies, Generic,Equivalency, Generic,Generic Equivalencies

Related Publications

C Hilgenstock, and G Schmiedel, and K G Bührens
January 2006, Arzneimittel-Forschung,
C Hilgenstock, and G Schmiedel, and K G Bührens
January 2007, Arzneimittel-Forschung,
C Hilgenstock, and G Schmiedel, and K G Bührens
January 2009, European journal of drug metabolism and pharmacokinetics,
C Hilgenstock, and G Schmiedel, and K G Bührens
January 2008, Arzneimittel-Forschung,
C Hilgenstock, and G Schmiedel, and K G Bührens
January 1988, Biopharmaceutics & drug disposition,
C Hilgenstock, and G Schmiedel, and K G Bührens
November 1996, Acta pharmaceutica Hungarica,
C Hilgenstock, and G Schmiedel, and K G Bührens
May 1988, International journal of clinical pharmacology, therapy, and toxicology,
C Hilgenstock, and G Schmiedel, and K G Bührens
January 2006, Pharmacology,
C Hilgenstock, and G Schmiedel, and K G Bührens
January 2009, Arzneimittel-Forschung,
C Hilgenstock, and G Schmiedel, and K G Bührens
November 2008, International journal of clinical pharmacology and therapeutics,
Copied contents to your clipboard!